Search for:
Search
Deciphera Pharmaceuticals, Inc.
About Us
Overview
Management
Board of Directors
Advisors
Funding and Support
Compliance
Our Pipeline
Overview
Our Medicine
Ripretinib (DCC-2618)
Rebastinib
DCC-3014
Expanded Access
Our Focus on Patients
Our Focus on Patients and Families
Gastrointestinal Stromal Tumors (GIST)
Breast Cancer
Tenosynovial Giant Cell Tumors (TGCT)
Our Research
Kinases in Cancer
Our Kinase Switch Control Platform
Presentations and Publications
Our Workplace
Our Culture and Values
Join Our Team
Investors
Stock Information
Stock Quote & Chart
Historical Price Lookup
Investment Calculator
Analyst Coverage
Press Releases
Deciphera in the News
Events and Presentations
Financial Information
SEC Filings
Corporate Governance
Documents & Charters
Management
Board of Directors
Investor Resources
FAQs
Contact IR
Email Alerts
Contact
Compliance
»
Overview
Management
Board of Directors
Advisors
Funding and Support
Compliance
State Disclosures
California Compliance Declaration
VT Prescribers – QINLOCK
®
Long Form
About Us
Overview
Management
Board of Directors
Advisors
Funding and Support
Compliance
Our Pipeline
Overview
Our Medicine
Ripretinib (DCC-2618)
Rebastinib
DCC-3014
Expanded Access
Our Focus on Patients
Our Focus on Patients and Families
Gastrointestinal Stromal Tumors (GIST)
Breast Cancer
Tenosynovial Giant Cell Tumors (TGCT)
Our Research
Kinases in Cancer
Our Kinase Switch Control Platform
Presentations and Publications
Our Workplace
Our Culture and Values
Join Our Team
Investors
Stock Information
Stock Quote & Chart
Historical Price Lookup
Investment Calculator
Analyst Coverage
Press Releases
Deciphera in the News
Events and Presentations
Financial Information
SEC Filings
Corporate Governance
Documents & Charters
Management
Board of Directors
Investor Resources
FAQs
Contact IR
Email Alerts
Contact